Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
SANTIS PHARMA from Thimister-Clermont, company number BE0421562592, closed financial year 2025 with a result of € 1.2 million after tax. For that financial year SANTIS PHARMA recorded revenue of € 17.9 million and equity of € 640,449. Compared with financial year 2024, the result moved from € 631,403 to € 1.2 million. Profitable, and profit is growing. The buffer shrank hard: equity is 88 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.
€ 640,449
▼ 88% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.2 million
▲ 94% vs 2024
Profit after tax over the fiscal year.
€ 99,050
▼ 34% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 5.9 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
33.7
▲ 5.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2 million
▲ 50% vs 2024
€ 59,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 93,533
▼ 34% vs 2024
Of which on lease € 4,774.
Debts at end 2025
€ 4.3 million
▼ 14% vs 2024
€ 608,924 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 219,173
▼ 87% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 6 days on average.
€ 601,646
▲ 227% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 18,578,590 | € 17,917,131 | ▼ 4% |
| Gross margin | € 805,851 | € 739,999 | - | - | |
| Profit after taxes | € 313,663 | € 325,239 | € 631,403 | € 1,223,846 | ▲ 94% |
| Equity | € 387,222 | € 712,461 | € 5,291,150 | € 640,449 | ▼ 88% |
| Total debts | € 1,949,571 | € 1,085,861 | € 6,869,627 | € 8,013,867 | ▲ 17% |
| Cash | € 428,625 | € 123,351 | € 150,259 | € 99,050 | ▼ 34% |
| Retained profit | € 360,036 | € 685,274 | € 4,746,845 | € 96,143 | ▼ 98% |
| Dividend | € 320,000 | € 0 | € 0 | € 5,874,548 | |
| Bank debt | € 496,594 | € 408,555 | € 4,987,491 | € 4,296,198 | ▼ 14% |
| Balance sheet total | € 2,336,793 | € 1,798,322 | € 12,160,777 | € 8,654,316 | ▼ 29% |
| Employees (FTE) | 5.9 | 4.4 | 28.1 | 33.7 | ▲ 5.6 |
Key figures of SANTIS PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SANTIS PHARMA?
What happened at SANTIS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- BERNARD LEMARCHAND stepped down as director. NBB
- CATHERINE DAUBY stepped down as director. NBB
- MONIQUE SCHMITZ stepped down as director. NBB
- MARIA MAGDALENA GROSCH-HENNES stepped down as director. NBB
- PIERRE DETHIER stepped down as director. NBB
- SC PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT stepped down as director. NBB
- PHILIPPE GEORIS stepped down as director. NBB
- MARC BREYER stepped down as director. NBB
In short
From € 313,663 profit in 2022 to € 1.2 million profit in 2025.
Paid € 855,933 in corporate taxes since 2022.
Best year ever: 2025, with € 1.2 million profit.
On average € 168,200 of value added per employee in 2023.
Management
The stake of SANTIS GROUP, PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SANTIS PHARMAThe shares are held by SANTIS GROUP (100%) and PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT (100%).
Directors
According to the 2025 annual accounts
BERNARD LEMARCHAND
Director
Also active at: PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT, SANTIS GROUP
since 2025 · until 2031
CATHERINE DAUBY
Director
Also active at: PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT, GENERATION 2000, COMEPAR 1, SANTIS GROUP
since 2025 · until 2031
MONIQUE SCHMITZ
Director
Also active at: PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT, GENERATION 2000, SANTIS GROUP
since 2025 · until 2031
MARIA MAGDALENA GROSCH-HENNES
Director
since 2025 · until 2031
PIERRE DETHIER
Director
Also active at: PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT, Fonds et Services Sociaux - Réseau Solidaris, GENERATION 2000, COMEPAR 5, SANTIS GROUP
since 2025 · until 2031
SC PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
Director · represented by HELENE GORRIA
Also active at: La Grande Pharmacie, Pharmacie du Perron, PHARMACIE LARDINOIS, SANTIS GROUP, Plate-Forme de Soins palliatifs de l'Est francophone, SOCIETE BEYNOISE DE PHARMACIE, V-IMMO, GROUPEMENT DES PHARMACIES COOPERATIVES DES PROVINCES FRANCOPHONES +5 more
since 2025 · until 2031
PHILIPPE GEORIS
Director
Also active at: PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT, GENERATION 2000, SANTIS GROUP
since 2025 · until 2031
since 2025 · until 2031
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de l'Avenir 12
4890 Thimister-Clermont
Rue Paul Janson 35
4420 Saint-Nicolas
Active since 1 January 1972
Rue des Français 220
4430 Ans
Active since 20 March 1979
Chaussée de Liège 426
4460 Grâce-Hollogne
Active since 1 April 1981
Rue du Centre 2
4460 Grâce-Hollogne
Active since 1 April 1981
Chaussée de Tongres 41
4000 Liège
Active since 1 January 1971
Place Gilles Gérard 33
4041 Herstal
Active since 1 August 1980
Rue des Grands Champs 6
4420 Saint-Nicolas
Active since 3 June 1999
Rue du Huit Mai 14
4460 Grâce-Hollogne
Active since 24 December 2002
Place Emile Vandervelde 14
4420 Saint-Nicolas
Active since 27 June 2003
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT same network
€ 109.5 million revenue · 2025
La Grande Pharmacie same network
€ 54,296 revenue · 2025
PHARMACIE LARDINOIS same network
€ 49,909 revenue · 2025
GENERATION 2000 same network
€ 971,059 revenue · 2025
V-IMMO same network
€ 300,000 revenue · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0421.562.592
- VAT number
- BE 0421.562.592
- Registered office
- Rue de l'Avenir 12, 4890 Thimister-Clermont
- Names & denominations
- SANTIS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 April 1981
- Peppol
- Active · Active since 10 Dec 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten